المؤلفون: Karpecki PM; Kentucky College of Optometry, Pikeville, Kentucky., Foster SA; Athens Eye Care, Athens, Ohio., Montaquila SM; West Bay Eye Associates, Warwick, Rhode Island., Kannarr SR; Kannarr Eye Care, Pittsburg, Kansas., Slonim CB; Oculos Development Services, LLC, Tampa, Florida., Meyer AR; Ocuphire Pharma, Farmington Hills, Michigan., Sooch MP; Ocuphire Pharma, Farmington Hills, Michigan., Jaber RM; Ocuphire Pharma, Farmington Hills, Michigan., Charizanis K, Yousif JE; Ocuphire Pharma, Farmington Hills, Michigan., Klapman SA; Ocuphire Pharma, Farmington Hills, Michigan., Amin AT; Ocuphire Pharma, Farmington Hills, Michigan., McDonald MB; New York University Langone Medical Center, New York, New York., Horn GD; LasikPlus, Cincinnati, Ohio., Lazar ES; elCON Medical, Buffalo, New York., Pepose JS

المصدر: Optometry and vision science : official publication of the American Academy of Optometry [Optom Vis Sci] 2021 Mar 01; Vol. 98 (3), pp. 234-242.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8904931 Publication Model: Print Cited Medium: Internet ISSN: 1538-9235 (Electronic) Linking ISSN: 10405488 NLM ISO Abbreviation: Optom Vis Sci Subsets: MEDLINE

مواضيع طبية MeSH: Adrenergic alpha-Antagonists/*pharmacology , Mydriatics/*administration & dosage , Phentolamine/*pharmacology , Pupil/*drug effects, Accommodation, Ocular/physiology ; Administration, Ophthalmic ; Adolescent ; Adult ; Cross-Over Studies ; Double-Blind Method ; Humans ; Male ; Ophthalmic Solutions ; Phenylephrine/administration & dosage ; Pupil Disorders ; Tropicamide/administration & dosage ; Young Adult